CRAFT-EP for Psychosis and Substance Use
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a program called CRAFT-EP (Community Reinforcement and Family Training for Early Psychosis) to assist families facing early psychosis and substance use issues. The goal is to determine if this program, delivered via video calls, can provide better support than usual treatments. Participants will receive either CRAFT-EP plus standard care or just the usual treatment. It suits family members concerned about a relative's alcohol or cannabis use who have regular contact with them. Participants must be able to use video conferencing and speak English. As an unphased trial, this study offers families a unique opportunity to explore innovative support methods for early psychosis and substance use.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that CRAFT-EP is safe for families experiencing early psychosis and substance use?
Research has shown that Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) is generally easy for participants to handle. In a previous study, researchers tested this telehealth method with families facing early psychosis and substance use issues. The study found it to be safe, with no major side effects reported. This suggests that CRAFT-EP can be a safe option for families seeking help with these challenges. While more research is always beneficial, current evidence indicates that participants tolerate this treatment well.12345
Why are researchers excited about this trial?
Researchers are excited about CRAFT-EP for psychosis and substance use because it integrates Community Reinforcement and Family Training specifically designed for early psychosis. Unlike traditional treatments, which often focus solely on the patient, CRAFT-EP involves family members in 8 weekly sessions of coaching to create a supportive environment for recovery. This method aims to enhance the effectiveness of standard Treatment as Usual (TAU) by fostering family involvement and reinforcement, potentially leading to better outcomes for both psychosis and substance use issues.
What evidence suggests that CRAFT-EP is effective for early psychosis and substance use?
Research has shown that Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP), which participants in this trial may receive, could assist families dealing with early psychosis and substance use. One study examined a version of CRAFT delivered through telehealth and found it practical and possibly beneficial for these families. This method focuses on enhancing family support and communication, potentially leading to better outcomes for those with early psychosis. By involving family members in treatment, CRAFT-EP aims to reduce substance use and improve mental health. Early results suggest this approach might be effective, but further research is needed to confirm.12356
Who Is on the Research Team?
Julie M McCarthy, PhD
Principal Investigator
Mclean Hospital
Are You a Good Fit for This Trial?
This trial is for individuals aged 18-70 who have used alcohol or cannabis in the past month, are not currently interested in quitting substance use, and have experienced early psychosis within the last six years. Family members concerned about their relative's substance use can participate if they speak English, can consent, and have video conferencing tools.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Community Reinforcement and Family Training for Early Psychosis (CRAFT-EP) with 8 weekly sessions of 60-90-minute coaching
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- CRAFT-EP
- TAU
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mclean Hospital
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator